1. Home
  2. APRE vs EEIQ Comparison

APRE vs EEIQ Comparison

Compare APRE & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • EEIQ
  • Stock Information
  • Founded
  • APRE 2006
  • EEIQ 2017
  • Country
  • APRE United States
  • EEIQ United States
  • Employees
  • APRE N/A
  • EEIQ N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • EEIQ Other Consumer Services
  • Sector
  • APRE Health Care
  • EEIQ Real Estate
  • Exchange
  • APRE Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • APRE 15.8M
  • EEIQ 13.8M
  • IPO Year
  • APRE 2019
  • EEIQ 2021
  • Fundamental
  • Price
  • APRE $3.05
  • EEIQ $1.06
  • Analyst Decision
  • APRE Strong Buy
  • EEIQ
  • Analyst Count
  • APRE 2
  • EEIQ 0
  • Target Price
  • APRE $15.50
  • EEIQ N/A
  • AVG Volume (30 Days)
  • APRE 22.6K
  • EEIQ 113.1K
  • Earning Date
  • APRE 11-07-2024
  • EEIQ 01-06-2025
  • Dividend Yield
  • APRE N/A
  • EEIQ N/A
  • EPS Growth
  • APRE N/A
  • EEIQ N/A
  • EPS
  • APRE N/A
  • EEIQ N/A
  • Revenue
  • APRE $1,310,839.00
  • EEIQ $6,454,461.00
  • Revenue This Year
  • APRE $134.21
  • EEIQ N/A
  • Revenue Next Year
  • APRE N/A
  • EEIQ N/A
  • P/E Ratio
  • APRE N/A
  • EEIQ N/A
  • Revenue Growth
  • APRE 130.31
  • EEIQ 13.32
  • 52 Week Low
  • APRE $2.15
  • EEIQ $0.60
  • 52 Week High
  • APRE $8.85
  • EEIQ $2.10
  • Technical
  • Relative Strength Index (RSI)
  • APRE 43.20
  • EEIQ 61.42
  • Support Level
  • APRE $3.02
  • EEIQ $0.94
  • Resistance Level
  • APRE $3.39
  • EEIQ $1.17
  • Average True Range (ATR)
  • APRE 0.30
  • EEIQ 0.10
  • MACD
  • APRE -0.01
  • EEIQ -0.00
  • Stochastic Oscillator
  • APRE 3.85
  • EEIQ 68.57

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University.

Share on Social Networks: